Home » Topics » Regulatory » Patents

Patents
RSS

Auransa identifies new agents for bacterial and fungal infections

May 20, 2022

New YAP1-TEAD interaction inhibitors identified at Vivace Therapeutics

May 19, 2022

TME Therapeutics discovers PIKfyve inhibitors

May 19, 2022

CXCR4-targeting compounds patented by the University of British Columbia, PHSA

May 19, 2022

New KRAS protein degraders synthesized at BioTheryX

May 19, 2022

Celgene, Zoetis describe new compounds for treating helminthic infections

May 19, 2022

Mission Therapeutics patents USP30 inhibitors

May 18, 2022

Evotec International discovers integrated stress response pathway modulators

May 18, 2022

University of Ljubljana presents dual TLR7/NOD2 agonists

May 18, 2022

Palacky University describes neuroprotective cholestane derivatives

May 18, 2022

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....